A group of retina specialists at the University of Alabama at Birmingham recently released the results of the second phase of the Multifocal Electroretinogram (MERG) study of patients placed on supplemental vitamins, minerals and …
Lucentis is a vascular endothelial growth factor (VEGF) inhibitor approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD). Lucentis is the only FDA-approved …
Vitreomacular adhesion is also associated with a poorer prognosis in certain major eye conditions, including Diabetic Retinopathy and Age-related Macular Degeneration (AMD). The MIVI-TRUST Program. The microplasmin Phase III program, …
